Epitope analysis of myeloperoxidase(MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis

被引:0
|
作者
Fujii, A
Tomizawa, K
Arimura, Y
Nagasawa, T
Ohashi, YY
Hiyama, T
Mizuno, S
Suzuki, K
机构
[1] Natl Inst Infect Dis, NIH, Dept Bioact Mol, Shinyuku Ku, Tokyo 1628640, Japan
[2] Kyorin Univ, Sch Med, Dept Internal Med 1, Tokyo, Japan
[3] Teikoku Hormone, Nat Prod Res Dept, Kawasaki, Kanagawa, Japan
关键词
neutrophils; myeloperoxidase; anti-neutrophil cytoplasmic autoantibodies; (ANCA)-MPO-ANCA; epitope analysis; glomerulonephritis;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim and methods: Epitope analysis of sera from 20 patients with myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis was examined by Western blotting using a panel set of recombinant deletion mutants of MPO. Sera from 19 patients reacted with recombinants of MPO heavy chain, whereas no serum reacted with the light chain regions. The high frequency sites were regions on the upstream of Met(341) (Ha region), on the upstream of Met(409) (Hb region) near the N-terminus of the MPO heavy chain and a region on the downstream of Gly(598) (Hg region) near the C-terminus. The epitope recognition profiles were classified into 2 groups. Group Al which had 1 or 2 regions in Ha, Hb and Hg, and group B, which had all 3 regions. Results: Incidence of alveolar hemorrhage (AH) and pulmonary fibrosis (PF) in group A was significantly higher than that in group B (AH: group A 9 of 13 (69.2%), group B 1 of 6 (16.7%) p < 0.05, PF: group A 10 of 13 (76.9%). group B 1 of 6 (16.7%) p < 0.05. AH and/or PH: group A 12 of 13 (92.3%) and group B 1 of 6 (16.7%) p < 0.01). Relapse rate for patients in the inactive stage in group A was significantly higher than that in group B (p < 0.05). T-cell reacted regions were Ha. Hb. Hg and the light chain of MPO recombinant fragments. Higher frequency of HLA typing with MHC class II DR9 was observed. Conclusion: These results indicate that MPO-ANCA recognizes the linear site of the heavy chain of the MPO molecule. The epitope recognition profiles are related to the clinical features. suggesting the pathogenesis of MPO-ANCA-associated glomerulonephritis.
引用
收藏
页码:242 / 252
页数:11
相关论文
共 50 条
  • [1] IgA nephropathy with myeloperoxidase anti-neutrophil cytoplasmic antibodies (MPO ANCA): A discrepancy between the histological activity and MPO ANCA
    Fujimoto T.
    Matsui M.
    Ikeda Y.
    Shiiki H.
    Umemura Y.
    Nonaka H.
    Dohi K.
    Clinical and Experimental Nephrology, 1999, 3 (4) : 307 - 310
  • [2] Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis
    Gan, Poh-Yi
    Holdsworth, Stephen R.
    Kitching, A. Richard
    Ooi, Joshua D.
    CELLULAR IMMUNOLOGY, 2013, 282 (01) : 21 - 27
  • [3] The role of myeloperoxidase and myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis
    Arimura, Yoshihiro
    Kawashima, Soko
    Yoshihara, Ken
    Komagata, Yoshinori
    Kaname, Shinya
    Yamada, Akira
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (05) : 634 - 637
  • [4] Development of a Certified Reference Material for myeloperoxidase-anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)
    Monogioudi, Evanthia
    Hutu, Dana Petronela
    Martos, Gustavo
    Sheldon, Joanna
    Schimmel, Heinz
    Meroni, Pier Luigi
    Zegers, Ingrid
    CLINICA CHIMICA ACTA, 2017, 467 : 48 - 50
  • [5] Immunopathologic co-localization of MPO, IgG, and C3 in glomeruli in human MPO-ANCA-associated glomerulonephritis
    Kawashima, Soko
    Arimura, Yoshihiro
    Sano, Katsuko
    Kudo, Akihiko
    Komagata, Yoshinori
    Kaname, Shinya
    Kawakami, Hayato
    Yamada, Akira
    CLINICAL NEPHROLOGY, 2013, 79 (04) : 292 - 301
  • [6] Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies (MPO-ANCA) in childhood onset Graves disease treated with propylthiouracil
    Fujieda, M
    Suzuki, J
    Sato, H
    Hattori, M
    Wada, N
    Tsuchiya, M
    Okamoto, N
    Murata, T
    Matsudaira, M
    Shimizu, M
    Ohta, K
    Naruse, K
    Sugihara, S
    Wakiguchi, H
    CLINICAL NEPHROLOGY, 2005, 63 (06) : 437 - 445
  • [7] A Panel Set for Epitope Analysis of Myeloperoxidase (MPO)-Specific Antineutrophil Cytoplasmic Antibody MPO-ANCA Using Recombinant Hexamer Histidine-Tagged MPO Deletion Mutants
    Kazuo Tomizawa
    Eriko Mine
    Asami Fujii
    Yuko Y. Ohashi
    Satoshi Yamagoe
    Yuki Hashimoto
    Akiko Ishida-Okawara
    Mie Ito
    Masaru Tanokura
    Takeki Yamamoto
    Yoshihiro Arimura
    Toshihiko Nagasawa
    Satoshi Mizuno
    Kazuo Suzuki
    Journal of Clinical Immunology, 1998, 18 : 142 - 152
  • [8] A panel set for epitope analysis of myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO-ANCA using recombinant hexamer histidine-tagged MPO deletion mutants
    Tomizawa, K
    Mine, E
    Fujii, A
    Ohashi, YY
    Yamagoe, S
    Hashimoto, Y
    Ishida-Okawara, A
    Ito, M
    Tanokura, M
    Yamamoto, T
    Arimura, Y
    Nagasawa, T
    Mizuno, S
    Suzuki, K
    JOURNAL OF CLINICAL IMMUNOLOGY, 1998, 18 (02) : 142 - 152
  • [9] No association of G-463A myeloperoxidase gene polymorphism with MPO-ANCA-associated vasculitis
    Fiebeler, A
    Borgmann, S
    Woywodt, A
    Haller, H
    Haubitz, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (04) : 969 - 971
  • [10] A novel autoantibody against moesin in the serum of patients with MPO-ANCA-associated vasculitis
    Suzuki, Koya
    Nagao, Tomokazu
    Itabashi, Mitsuyo
    Hamano, Yoshitomo
    Sugamata, Ryuichi
    Yamazaki, Yuji
    Yumura, Wako
    Tsukita, Sachiko
    Wang, Pi-Chao
    Nakayama, Toshinori
    Suzuki, Kazuo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (06) : 1168 - 1177